New research is shedding light on the benefits of GLP-1 receptor agonist use in patients with celiac disease, including a significant survival benefit and reduced risk of iron deficiency anemia.1
The data were presented at the
GLP-1 RAs Reduce Anemia Risk in Patients with Celiac Disease
